Bryte is a skilled patent agent with more than 13 years of experience representing clients in patent preparation and procurement as well as supporting attorneys providing strategic IP advice related to corporate transactions and licensing.
She manages large patent portfolios globally and handles matters for clients in diverse fields including pharmaceutical, biotech and material science such as OLED, oil and gas, water purification and inorganic catalyst technologies. Bryte has particular expertise with small molecule pharmaceuticals with relevance to cancer, cardiovascular indications, blood pathologies and immunology.
Prior to joining Fenwick, Bryte was a patent agent with an Am Law 100 firm, where she secured patents for Orange Book listed and licensed drug products, and prepared expert declarations in support of secondary indicia of patentability, appeal briefs and petitions for patent term extension. She also performed freedom to operate, patentability and invalidity analysis and due diligence.
Bryte received her Ph.D. from Columbia University, where she studied the design and synthesis of small molecule organo-metallic enzyme mimics, which she characterized by x-ray crystallography and computer modeling. While at Columbia, Bryte co-founded Women in Science at Columbia (WISC)—an organization dedicated to the outreach, support and advancement of women, underrepresented minorities and their advocates in the science, technology, engineering and mathematical graduate fields at the university.